ArticleJournal of clinical medicine2025

Super Responders in Moderate-to-Severe Atopic Dermatitis Under Treatment with Dupilumab: An Explorative Real-World Study.

Luca Mastorino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.